SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Sept. 10, 2001 Biozhem Cosmeceuticals Inc., (Biozhem) (OTCBB:BZHM) today announced that Emmy-winning actress Lindsay Wagner has signed an agreement to be the celebrity host of its worldwide infomercial for the RevitaCel Skin Care System. The infomercial will be the cornerstone of the marketing launch for its scientifically based new line, the RevitaCel System which features the breakthrough ingredient, NouriCel(TM), produced by Advanced Tissue Sciences Inc., of La Jolla, Calif. (Nasdaq:ATIS). "As a well-respected advocate and author of two books on natural ways to achieve a healthier lifestyle, Lindsay Wagner is the perfect personality for RevitaCel," said Biozhem's board chairman, Jim Chapin. "Her personal and professional commitment to advancing human potential colors every aspect of her life, as is seen in the many 'issue-oriented' films she has produced and starred in for television. We believe that her talent and commitment will help ensure that the significant benefits of our break-through skin care line will be realized by consumers." From her Emmy-winning role in "Bionic Woman," to her most recent work, Wagner has captured the imagination and respect of people around the world. For more than a decade, her work as an actress and producer has received recognition for addressing issues critical to our society, such as domestic violence, and the recognition of women who have made special contributions to the world around them. Reached at her home in the Los Angeles area, Wagner commented on the new venture: "I've spent much of my adult life exploring and researching natural approaches to health. After testing the RevitaCel products on myself, my family, and my friends, -- and seeing such positive results, I was delighted to join Biozhem and Advanced Tissue Science in bringing this wonderful new skin care technology to the public. "As someone with very sensitive skin, I know how difficult it is to find a product that gets such results without irritation. It's about time someone thought to use 'nature's' own way to revitalize our skin and make it healthier, not to mention -- younger looking." The premier product in the RevitaCel line, Replenishing Complex, contains as its main ingredient NouriCel, from Advanced Tissue Sciences. A natural by-product of the company's tissue engineering process for medical applications, NouriCel contains a unique combination of naturally derived human growth factors, soluble collagens, matrix proteins, amino acids and powerful antioxidants to replenish the skin topically with everything it produced naturally when it was younger. RevitaCel Replenishing Complex with NouriCel enhances the skin's natural repair process, making the skin look and feel younger and more vibrant. Gail Naughton, Ph.D., president of Advanced Tissue Sciences, added: "We are excited and proud to have Lindsay Wagner representing the RevitaCel Skin Care System from Biozhem containing our revolutionary new bio-engineered ingredient, NouriCel. "Lindsay is naturally beautiful and is a perfect endorsement for this non-surgical, yet scientifically proven approach to helping skin look and feel younger." "We feel a strong alignment in values with Lindsay," Naughton continued, "and are pleased to see that she is excited about how our core technology provides significant patient benefits in the area of burn and wound healing. "The ability to take a by-product of that medical technology and offer a totally new, highly scientific, yet natural approach to skin rejuvenation is an amazing benefit of our commitment to advances in biomedical research that allows Lindsay's involvement with us." Biozhem Cosmeceuticals is a developer and retailer of premium quality skin care products for women and men. For further information on the product, contact Biozhem at 800/270-8237 ext. 205. For information on the company, contact investor relations at 888/215-9630. Statements about the company's future expectations and all other statements in this news release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that is defined in the Private litigation Reform Act of 1995. The company intends that such forward-looking statements be subject to the safe harbor created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the company's actual results could differ materially from expected results.